Hairy Cell Leukemia Clinical Trials

• Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia
  ClinicalTrials.gov Identifier: NCT00005619 - Active, not recruiting
  refractory hairy cell leukemia; progressive hairy cell leukemia, initial treatment
  
• Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia
  ClinicalTrials.gov Identifier: NCT00003746 - Active, not recruiting
  untreated hairy cell leukemia; progressive hairy cell leukemia, initial treatment; Prolymphocytic Leukemia
  
• Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy
  ClinicalTrials.gov Identifier: NCT00003757 - Active, not recruiting
  refractory hairy cell leukemia; progressive hairy cell leukemia, initial treatment
  
• BL22 Immunotoxin to Treat Hairy Cell Leukemia
  ClinicalTrials.gov Identifier: NCT00071318 - Recruiting
  Leukemia, Hairy Cell
  
• VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00049686 - Active, not recruiting
  acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; Hairy Cell Leukemia; myelodysplastic and myeloproliferative disease; ...
  
• Flavopiridol, Fludarabine, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00058227 - Active, not recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; Hairy Cell Leukemia
  
• UCN-01 and Fludarabine to Treat Lymphoma and Leukemia
  ClinicalTrials.gov Identifier: NCT00001822 - Recruiting
  Chronic Lymphocytic Leukemia; Hairy Cell Leukemia; Leukemia; Lymphoma; Waldenstrom Macroglobulinemia
  
• Phase I Study of BL22, a Recombinant Immunotoxin for Treatment of CD22+ Leukemias and Lymphomas
  ClinicalTrials.gov Identifier: NCT00001792 - No longer recruiting
  Chronic Lymphocytic Leukemia; Hairy Cell Leukemia; Non Hodgkin's Lymphoma; Prolymphocytic Leukemia
  
• LMB-2 Immunotoxin in Treating Patients With Recurrent or Refractory Hairy Cell Leukemia
  ClinicalTrials.gov Identifier: NCT00337311 - Recruiting
  Leukemia
  
• BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell Leukemia
  ClinicalTrials.gov Identifier: NCT00074048 - Recruiting
  Leukemia
  
• 2CDA With Rituximab in Hairy Cell Leukemia
  ClinicalTrials.gov Identifier: NCT00412594 - Recruiting
  Leukemia
  
• A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia
  ClinicalTrials.gov Identifier: NCT00001567 - Completed
  Hairy Cell Leukemia
  
• Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease
  ClinicalTrials.gov Identifier: NCT00462189 - Recruiting
  Leukemia; Hairy Cell Leukemia; HCL
  
• Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia
  ClinicalTrials.gov Identifier: NCT00021983 - Completed
  Leukemia
  
• Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer
  ClinicalTrials.gov Identifier: NCT00004086 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002531 - Active, not recruiting
  non-T, non-B adult acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia; B-cell adult acute lymphoblastic leukemia; ...
  
• Combination Chemotherapy Followed By Antiviral Therapy and Interferon alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma
  ClinicalTrials.gov Identifier: NCT00041327 - Active, not recruiting
  stage I adult T-cell leukemia/lymphoma; stage II adult T-cell leukemia/lymphoma; stage III adult T-cell leukemia/lymphoma; ...
  
• Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00313079 - Recruiting
  Leukemia; Leukemia, Lymphocytic; Leukemia, B-Cell; Leukemia, B-Cell, Acute
  
• Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00002704 - Active, not recruiting
  B-cell childhood acute lymphocytic leukemia; TdT positive childhood acute lymphocytic leukemia; recurrent childhood acute lymphocytic leukemia; ...
  
• Denileukin Diftitox in Patients With T-Cell Leukemia/Lymphoma
  ClinicalTrials.gov Identifier: NCT00138190 - Recruiting
  recurrent adult T-cell leukemia/lymphoma; stage I adult T-cell leukemia/lymphoma; stage II adult T-cell leukemia/lymphoma; ...
  
• Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00072007 - Active, not recruiting
  B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
  
• High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002788 - Active, not recruiting
  stage III chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; refractory chronic lymphocytic leukemia; ...
  
• T-Cell and B-Cell Depletion in Allogeneic Peripheral Blood Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00306332 - Recruiting
  Leukemia, Myeloid; Leukemia, Lymphocytic; Myelodysplastic Syndrome; Leukemia, Myeloid, Chronic; Lymphoma
  
• Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00061945 - Active, not recruiting
  B-cell adult acute lymphoblastic leukemia; L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; ...
  
• Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00025545 - Active, not recruiting
  adult acute lymphoblastic leukemia in remission; recurrent adult acute myeloid leukemia; acute undifferentiated leukemia; ...
  
• Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00186823 - Active, not recruiting
  Acute Lymphoblastic Leukemia; Acute Myelocytic Leukemia; Chronic Myeloid Leukemia; Juvenile Myelomonocytic Leukemia; Hemoglobinuria, Paroxysmal
  
• Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003248 - Active, not recruiting
  stage II chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia; stage IV chronic lymphocytic leukemia; ...
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00008190 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; childhood acute myeloid leukemia; ...
  
• Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00005801 - Active, not recruiting
  adult acute differentiated monocytic leukemia (M5b); adult acute myeloblastic leukemia without maturation (M1); ...
  
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003671 - Active, not recruiting
  B-cell childhood acute lymphocytic leukemia; untreated childhood acute lymphocytic leukemia
  
• Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-Progenitor Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00313053 - Recruiting
  Lymphocytic Leukemia, B Cell, Acute; Leukemia, B-Cell; Leukemia, Lymphocytic, Acute; Lymphoblastic Leukemia, Acute, Childhood; Leukemia, Lymphocytic, Acute, L1
  
• Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults
  ClinicalTrials.gov Identifier: NCT00001637 - Active, not recruiting
  Chronic Lymphocytic Leukemia; Graft vs Host Disease; Leukemia; Myelodysplastic Syndrome; Myeloid Leukemia
  
• Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00020670 - Active, not recruiting
  recurrent childhood acute lymphoblastic leukemia; recurrent adult acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia; ...
  
• High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00002945 - Active, not recruiting
  adult acute myelomonocytic leukemia (M4); untreated adult acute myeloid leukemia; adult acute monocytic leukemia (M5); ...
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
  ClinicalTrials.gov Identifier: NCT00096135 - Recruiting
  recurrent childhood acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia; T-cell childhood acute lymphoblastic leukemia; ...
  
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00016302 - Active, not recruiting
  untreated childhood acute lymphoblastic leukemia; T-cell childhood acute lymphoblastic leukemia
  
• Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00005603 - Active, not recruiting
  childhood acute lymphoblastic leukemia in remission; B-cell childhood acute lymphoblastic leukemia
  
• Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00005585 - Active, not recruiting
  childhood acute lymphoblastic leukemia in remission; B-cell childhood acute lymphoblastic leukemia
  
• Bevacizumab and Combination Chemotherapy in Patients With Hematologic Cancers
  ClinicalTrials.gov Identifier: NCT00217425 - Recruiting
  anaplastic large cell lymphoma; stage I adult T-cell leukemia/lymphoma; stage II adult T-cell leukemia/lymphoma; ...
  
• Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00006226 - Active, not recruiting
  refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00086775 - Active, not recruiting
  refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Did Not Respond to Fludarabine
  ClinicalTrials.gov Identifier: NCT00104858 - Recruiting
  refractory chronic lymphocytic leukemia; recurrent small lymphocytic lymphoma; B-cell Chronic Lymphocytic Leukemia; ...
  
• Total Body Irradiation, Thiotepa, and Fludarabine Followed By A Donor Peripheral Blood Stem Cell Transplant in Treating Young Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00112567 - Active, not recruiting
  childhood acute lymphoblastic leukemia; childhood acute myeloid leukemia and other myeloid malignancies; Chronic Myelogenous Leukemia; ...
  
• Hu-Mik-(Beta)1 to Treat T-Cell Large Granular Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00076180 - Recruiting
  Leukemia, T-Cell
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00002831 - Active, not recruiting
  Leukemia, Myeloid; Leukemia, Myeloid, Chronic
  
• Fludarabine and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00119340 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; ...
  
• Selective T-Cell Depletion to Reduce Graft-Versus-Host-Disease in Patients Receiving Stem Cell Transplantation to Treat Leukemia, Lymphoma or Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00016484 - Recruiting
  Graft vs Host Disease; Myelodysplastic Syndromes; Leukemia; Leukemia, Myeloid; Leukemia, Myelomonocytic, chronic; Leukemia, Lymphocytyc; Lymphoma; ...
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002761 - Active, not recruiting
  relapsing chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
  
• Donor Bone Marrow Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
  ClinicalTrials.gov Identifier: NCT00005622 - Active, not recruiting
  acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ...
  
• Stem Cell Transplantation for Patients with Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00152139 - Active, not recruiting
  Acute Lymphoblastic Leukemias; Acute Myelocytic Leukemia; Chronic Myeloid Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic Syndrome; ...
  
• Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003727 - Active, not recruiting
  relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
  
• Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00107354 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; ...
  
• Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00006097 - Active, not recruiting
  refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• Fludarabine and Rituximab Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00098670 - Active, not recruiting
  B-cell Chronic Lymphocytic Leukemia; stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
  
• Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia
  ClinicalTrials.gov Identifier: NCT00002832 - Active, not recruiting
  Leukemia, Myeloid, Chronic; Myelodysplastic Syndromes; Leukemia, Myeloid; Leukemia, Lymphocytic
  
• Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003783 - Active, not recruiting
  L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; ...
  
• Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00024440 - Active, not recruiting
  refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00004056 - Active, not recruiting
  childhood acute megakaryocytic leukemia (M7); untreated childhood acute myeloid leukemia; ...
  
• Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00017108 - Active, not recruiting
  stage III chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00513175 - Recruiting
  Acute Myeloid Leukemia; Myelodysplasia; Acute Lymphoblastic Leukemia; Chronic Lymphocytic Leukemia; Follicular Lymphoma; Multiple Myeloma; NHL; Myeloproliferative Diseases; Chronic Myeloid Leukemia; Renal Cell Carcinoma; Aplastic Anemia
  
• Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Lymphoma
  ClinicalTrials.gov Identifier: NCT00006252 - Active, not recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia
  
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002549 - Active, not recruiting
  adult acute myelomonocytic leukemia (M4); untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
  
• Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00049075 - Active, not recruiting
  B-cell Chronic Lymphocytic Leukemia; stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
  
• Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00005829 - Active, not recruiting
  refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• Fludarabine, Alemtuzumab, and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Donor White Blood Cell Infusion in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00416884 - Active, not recruiting
  Leukemia
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission
  ClinicalTrials.gov Identifier: NCT00002768 - Active, not recruiting
  adult acute differentiated monocytic leukemia (M5b); adult acute myeloblastic leukemia without maturation (M1); ...
  
• Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00003868 - Active, not recruiting
  adult acute myeloid leukemia; childhood acute myeloid leukemia; secondary acute myeloid leukemia
  
• Donor Stem Cell Transplantation With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00047268 - Active, not recruiting
  atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; juvenile myelomonocytic leukemia; myelodysplastic and myeloproliferative disease; ...
  
• Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00003056 - Active, not recruiting
  Lymphoma; Leukemia
  
• Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00004898 - Active, not recruiting
  Leukemia; Lymphoma
  
• Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00003217 - Active, not recruiting
  Burkitt's Lymphoma; B-cell childhood acute lymphocytic leukemia; stage IV childhood small noncleaved cell lymphoma; ...
  
• Chemotherapy, Low-Dose Total-Body Irradiation, and Peripheral Stem Cell Transplantation Followed By Chemotherapy and Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00003145 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; accelerated phase chronic myelogenous leukemia; ...
  
• Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00006363 - Active, not recruiting
  adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
  
• Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00005946 - Active, not recruiting
  Leukemia; Lymphoma
  
• Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003073 - Active, not recruiting
  leptomeningeal metastases; recurrent childhood large cell lymphoma; recurrent childhood acute myeloid leukemia; childhood diffuse large cell lymphoma; ...
  
• Chemotherapy, Biological Therapy, and/or Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00025402 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
  
• A Study to Evaluate the Treatment of Previously Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL)
  ClinicalTrials.gov Identifier: NCT00302861 - Active, not recruiting
  B-Cell Chronic Lymphocytic Leukemia
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00027924 - Active, not recruiting
  Myeloid Leukemia; Refractory Anemia
  
• Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00004218 - Active, not recruiting
  stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; ...
  
• Bone Marrow Transplantation in Treating Patients With Hematologic Cancers
  ClinicalTrials.gov Identifier: NCT00005797 - Active, not recruiting
  acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ...
  
• Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00281918 - Active, not recruiting
  Leukemia
  
• Lower-Dose Chemotherapy and Stem Cell Transplantation to Treat Childhood Leukemias and Lymphomas
  ClinicalTrials.gov Identifier: NCT00013533 - Recruiting
  Hodgkin Lymphoma; Lymphocytic Leukemia; Mixed Cell Leukemia; Myelodysplastic Syndrome; Non Hodgkin's Lymphoma
  
• Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Leukemia Following Total Body Irradiation and Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00510315 - Recruiting
  Leukemia; Leukemia Survivors
  
• Total-Body Irradiation Plus Chemotherapy Followed By Donor Bone Marrow Transplantation in Treating Children With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00028730 - Active, not recruiting
  acute leukemia; childhood large cell lymphoma; childhood lymphoblastic lymphoma; childhood small noncleaved cell lymphoma; chronic leukemia; ...
  
• Stem Cell Transplant for Children Less Then Two Years with Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00145626 - Recruiting
  Acute Myeloid Leukemia; Acute Lymphocytic Leukemia; Myelodysplasia
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002674 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
  
• Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003829 - Active, not recruiting
  stage II chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; stage I chronic lymphocytic leukemia; ...
  
• Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00103285 - Recruiting
  untreated childhood acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia
  
• 506U78 in Treating Patients With Refractory Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00002970 - Active, not recruiting
  recurrent childhood lymphoblastic lymphoma; T-cell childhood acute lymphoblastic leukemia; recurrent childhood acute lymphoblastic leukemia
  
• Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00075725 - Recruiting
  untreated childhood acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia; ...
  
• Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00031655 - Active, not recruiting
  adult acute lymphoblastic leukemia in remission; childhood acute lymphoblastic leukemia in remission
  
• OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00081055 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00098371 - Recruiting
  B-cell Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; refractory chronic lymphocytic leukemia
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002638 - Active, not recruiting
  recurrent childhood acute lymphoblastic leukemia
  
• 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00006020 - Active, not recruiting
  recurrent adult acute lymphoblastic leukemia; L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; ...
  
• Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00004918 - Active, not recruiting
  adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• Autologous Peripheral Stem Cell or Bone Marrow Transplant Using Laboratory-Treated Cells in Treating Patients With Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00245115 - Active, not recruiting
  Leukemia
  
• Fludarabine Followed by Campath-1H in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00004857 - Active, not recruiting
  stage II chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; stage I chronic lymphocytic leukemia; ...
  
• Fludarabine, Total-body Irradiation, Donor Peripheral Stem Cell Transplantation, and Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00005799 - Active, not recruiting
  Leukemia; Renal Cell Cancer; Lymphoma; Eye Cancer; Kidney Cancer
  
• Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00005948 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; refractory chronic myelogenous leukemia